AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Advances in ALL treatment may lead to elimination of irradiation.
2004 DEC 2 - (NewsRx.com & NewsRx.net) -- Improved risk classification for patients with acute lymphoblastic leukemia (ALL), coupled with more intensive intrathecal chemotherapy for high risk patients and the use of a drug called dexamethasone, could one day permit physicians to omit irradiation as a part of routine treatment.
These findings emerged from a clinical trial conducted by investigators at St. Jude Children's Research Hospital. For intrathecal chemotherapy the drugs are injected into the cerebrospinal fluid-filled spaces between the thin membranes covering the spinal cord.
The researchers base their conclusion on results of a study of ALL treatment at St. Jude called Total Therapy Study XIIIB, which are reported in the November 1 issue of the journal Blood.
The overall 5-year event-free survival rate of the children in Study XIIIB was just above 80%, and the overall survival rate was about 86%, according to the researchers.
The researchers substituted dexamethasone for the routinely used drug prednisone to achieve greater antileukemic effects in both the central nervous system (brain and spinal cord) and the blood stream.
The investigators also used more precise criteria to identify those children who should get more intensive intrathecal and intravenous therapy because they were at high risk for treatment failure.
Success of the modified chemotherapy treatment of XIIIB is significant because it established the importance of intensifying intrathecal chemotherapy early in treatment, and also set the stage for the current St. Jude clinical trial that omits the use of cranial irradiation in all patients, according to Ching-Hon Pui, MD.
- Improved Treatment for Acute Lymphoblastic Leukemia Offers Hope for Eliminating...
- Press release article from: PR Newswire November 1, 2004 700+ words
...doses over time than did low-risk patients. Patients considered at high...free-survival rate of low-risk patients in Study XIIIB was about 89 percent, while the rate for high-risk patients was about 74 percent. Only...
- High Risk Patients Gain Access to Percutaneous MitraClip(TM) Device to Reduce...
- Press release article from: PR Newswire March 19, 2007 700+ words
...Expansion of EVEREST study to include High Risk Patients - Cleveland Clinic Foundation Treats...study was only available to lower-risk patients recommended for surgery. "The new...investigators the ability to offer higher- risk patients a less-invasive option for correcting...
- Guidant's Carotid Artery Stenting Trials Demonstrate Positive Outcomes in...
- Press release article from: Business Wire March 7, 2004 700+ words
...Revascularization of Carotids in High Risk Patients) series of clinical trials. The ARCHeR...ARCHeR trials demonstrated that high-risk patients benefited from being treated with carotid...Solutions, Guidant Corporation. "High-risk patients in these trials had a low rate of stroke...
- Guidant Completes Enrollment in Clinical Trial to Study Carotid Artery Stenting...
- Press release article from: Business Wire December 17, 2002 700+ words
...ineligible for surgery or at high surgical-risk. Patients with carotid artery disease are at...Revascularization of Carotids in High-Risk Patients), the trial is a prospective, non...approach the treatment of high surgical-risk patients with carotid artery disease." "ARCHeR...
- Are high-quality cardiac surgeons less likely to operate on high-risk patients...
- Magazine article from: Health Services Research Glance, Laurent G. Dick, Andrew Mukamel, Dana B. Li, Yue Osler, Turner M. February 1, 2008 700+ words
...vulnerable patient population of high-risk patients will be increasingly denied access...that they refused to operate on high-risk patients on at least one occasion (Burack et...were more reluctant to treat high-risk patients as a result of public reporting of...
- Statins for very-high-risk patients.(Drug Update)
- Magazine article from: Family Practice News Mechcatie, Elizabeth. Zoler, Mitchel L. August 1, 2005 700+ words
...will usually be adequate for lower-risk patients who do not need as large a reduction...cholesterol goal for very-high-risk patients was set dramatically lower, based...previously considered adequate for high-risk patients. The study's impact was highlighted...
- Statins for very-high-risk patients.(DRUG UPDATE)
- Magazine article from: Internal Medicine News Mechcatie, Elizabeth Zoler, Mitchel L. August 1, 2005 700+ words
...will usually be adequate for lower-risk patients who do not need as large a reduction...cholesterol goal for very-high-risk patients was set dramatically lower, based...previously considered adequate for high-risk patients. The study's impact was highlighted...
- Carotid stenting far superior to surgery for high-risk patients.
- Newspaper article from: Medical Device Daily March 26, 2004 700+ words
...far superior to surgery for high-risk patients A Medical Device Daily Staff Report...Revascularization of Carotids in High-Risk Patients (ARCHeR) study echoed those findings...stenting. The study involved 334 high-risk patients randomized to the two groups; the...
Source: HighBeam Research, Advances in ALL treatment may lead to elimination of irradiation.